Cargando…
Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report
Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize lab...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497901/ https://www.ncbi.nlm.nih.gov/pubmed/28725789 http://dx.doi.org/10.1177/2374289517701067 |
_version_ | 1783248212274970624 |
---|---|
author | Crawford, James M. Shotorbani, Khosrow Sharma, Gaurav Crossey, Michael Kothari, Tarush Lorey, Thomas S. Prichard, Jeffrey W. Wilkerson, Myra Fisher, Nancy |
author_facet | Crawford, James M. Shotorbani, Khosrow Sharma, Gaurav Crossey, Michael Kothari, Tarush Lorey, Thomas S. Prichard, Jeffrey W. Wilkerson, Myra Fisher, Nancy |
author_sort | Crawford, James M. |
collection | PubMed |
description | Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize laboratory-driven innovations and test their valuation in diverse regional marketplaces in the United States. We provide recommendations from the inaugural March 2016 meeting of Project Santa Fe. Specifically, in the transition from volume-based to value-based health care, clinical laboratories are called upon to provide programmatic leadership in reducing total cost of care through optimization of time-to-diagnosis and time-to-effective therapeutics, optimization of care coordination, and programmatic support of wellness care, screening, and monitoring. This call to action is more than working with industry stakeholders on the basis of our expertise; it is providing leadership in creating the programs that accomplish these objectives. In so doing, clinical laboratories can be effectors in identifying patients at risk for escalation in care, closing gaps in care, and optimizing outcomes of health care innovation. We also hope that, through such activities, the evidence base will be created for the new value propositions of integrated laboratory networks. In the very simplest sense, this effort to create “Clinical Lab 2.0” will establish the impact of laboratory diagnostics on the full 100% spend in American healthcare, not just the 2.5% spend attributed to in vitro diagnostics. In so doing, our aim is to empower regional and local laboratories to thrive under new models of payment in the next era of American health care delivery. |
format | Online Article Text |
id | pubmed-5497901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54979012017-07-06 Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report Crawford, James M. Shotorbani, Khosrow Sharma, Gaurav Crossey, Michael Kothari, Tarush Lorey, Thomas S. Prichard, Jeffrey W. Wilkerson, Myra Fisher, Nancy Acad Pathol Regular Article Project Santa Fe was established both to provide thought leadership and to help develop the evidence base for the valuation of clinical laboratory services in the next era of American healthcare. The participants in Project Santa Fe represent major regional health systems that can operationalize laboratory-driven innovations and test their valuation in diverse regional marketplaces in the United States. We provide recommendations from the inaugural March 2016 meeting of Project Santa Fe. Specifically, in the transition from volume-based to value-based health care, clinical laboratories are called upon to provide programmatic leadership in reducing total cost of care through optimization of time-to-diagnosis and time-to-effective therapeutics, optimization of care coordination, and programmatic support of wellness care, screening, and monitoring. This call to action is more than working with industry stakeholders on the basis of our expertise; it is providing leadership in creating the programs that accomplish these objectives. In so doing, clinical laboratories can be effectors in identifying patients at risk for escalation in care, closing gaps in care, and optimizing outcomes of health care innovation. We also hope that, through such activities, the evidence base will be created for the new value propositions of integrated laboratory networks. In the very simplest sense, this effort to create “Clinical Lab 2.0” will establish the impact of laboratory diagnostics on the full 100% spend in American healthcare, not just the 2.5% spend attributed to in vitro diagnostics. In so doing, our aim is to empower regional and local laboratories to thrive under new models of payment in the next era of American health care delivery. SAGE Publications 2017-04-18 /pmc/articles/PMC5497901/ /pubmed/28725789 http://dx.doi.org/10.1177/2374289517701067 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Regular Article Crawford, James M. Shotorbani, Khosrow Sharma, Gaurav Crossey, Michael Kothari, Tarush Lorey, Thomas S. Prichard, Jeffrey W. Wilkerson, Myra Fisher, Nancy Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title | Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title_full | Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title_fullStr | Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title_full_unstemmed | Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title_short | Improving American Healthcare Through “Clinical Lab 2.0”: A Project Santa Fe Report |
title_sort | improving american healthcare through “clinical lab 2.0”: a project santa fe report |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497901/ https://www.ncbi.nlm.nih.gov/pubmed/28725789 http://dx.doi.org/10.1177/2374289517701067 |
work_keys_str_mv | AT crawfordjamesm improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT shotorbanikhosrow improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT sharmagaurav improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT crosseymichael improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT kotharitarush improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT loreythomass improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT prichardjeffreyw improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT wilkersonmyra improvingamericanhealthcarethroughclinicallab20aprojectsantafereport AT fishernancy improvingamericanhealthcarethroughclinicallab20aprojectsantafereport |